Paper Details

  1. Home
  2. Paper Details

Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials.

Author: FanshaweThomas R, McCarthyNoel D, Ordóñez-MenaJosé M

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Metronidazole is the current first-choice treatment for giardiasis, the most common intestinal protozoal infection worldwide. Although other drugs with potentially higher efficacy or fewer side effects are gaining popularity, evidence is limited due to a lack of randomized controlled trials (RCTs) comparing treatment options. Network meta-analysis (NMA) can be used to compare multiple treatments when direct evidence is limited.
Paper Details　
Original Abstract of the Article :
Giardiasis is the commonest intestinal protozoal infection worldwide. The current first-choice therapy is metronidazole. Recently, other drugs with potentially higher efficacy or with fewer and milder side effects have increased in popularity, but evidence is limited by a scarcity of randomized cont...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890742/

データ提供：米国国立医学図書館（NLM）

Giardiasis: Finding the Right Treatment

Giardiasis, an intestinal infection caused by the parasite Giardia lamblia, is a common health problem worldwide. This systematic update of the literature and network meta-analysis of randomized clinical trials (RCTs) provides a comprehensive overview of the available treatments for giardiasis. The authors examine the efficacy of various medications, including metronidazole, tinidazole, nitazoxanide, albendazole, and paromomycin, comparing their effectiveness and side effect profiles. The analysis reveals that metronidazole remains the current first-choice therapy, while other drugs offer potential benefits in specific cases.

Navigating the Treatment Options: A Guide for Clinicians

This study provides valuable insights for clinicians managing patients with giardiasis. By comparing the efficacy and safety of various medications, the authors offer a comprehensive overview of treatment options. This information can help clinicians make informed decisions based on individual patient characteristics and clinical presentation.

A Global Challenge: Seeking Effective Solutions

Giardiasis is a significant health concern, particularly in developing countries where access to clean water and sanitation can be limited. This study highlights the need for effective and affordable treatment options for giardiasis. The authors' comprehensive analysis of available therapies provides valuable information for clinicians and researchers working to address this global health challenge. Just as a camel adapts to the harsh desert environment, we need to adapt our approach to treating giardiasis, finding solutions that are effective, safe, and accessible to all.

Dr. Camel's Conclusion

This study provides a comprehensive overview of the available treatments for giardiasis. The authors’ analysis reveals that metronidazole remains the current first-choice therapy, while other drugs offer potential benefits in specific cases. The study underscores the importance of ongoing research and development to improve treatment options for this common and often debilitating infection.

Date :
  1. Date Completed 2019-04-23
  2. Date Revised 2019-04-23
Further Info :

Pubmed ID

29186570

DOI: Digital Object Identifier

PMC5890742

Related Literature

Article Analysis
・Side Effects of tinidazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.